Calcium antagonism of the inhibitory effect of normorphine on the ileum of the morphine-tolerant and nontolerant guinea pig.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to E L Way.
Explore the source record for details and available documents.
Intracerebroventricular (i.c.v.) administration of subanalgesic doses of beta- and leucine-endorphin in mice 15 min before subcutaneous morphine injection, significantly enhanced the analgesic effects of the morphine as measured by the tail-flick assay. A similar effect was seen with levorphanol analgesia but not enhancement of leucine- or methionine-enkephalin analgesia by beta-endorphin was observed. The same doses of the endorphins did not affect the development of single-dose morphine tolerance and dependence. Leucine-enkephalin failed to affect morphine analgesia, tolerance or dependence development, while low doses of methionine-enkephalin administered i.c.v. were observed to have an antagonistic effect on morphine analgesia without affecting tolerance or dependence development. Neither endephalin had any effect on beta-endorphin analgesia.
Explore the source record for details and available documents.
To assess the effects of calcium ion chelation on narcotic tolerance development, adult Sprague-Dawley rats were implanted with i.c.v. cannulae connected to osmotic minipumps for continuous infusions of saline or EGTA (2 mumol/24 h) during chronic morphinization by s.c. pellet implantation. Additional rats receiving the same morphine pellet treatment but without minipumps served as non-surgical controls. After 64 h the minipumps and pellets were removed and narcotic tolerance was assessed by the tail-flick technique. A positive analgetic response to an 8.50 mg/kg s.c. dose of morphine sulfate was noted in 6/12 no-minipump controls and 4/9 saline-infused controls. In placebo-treated rats caused no alteration of either baseline tail-flick latencies or in analgetic responsiveness to lower doses of morphine. It is concluded that the enhancement of morphine tolerance by EGTA (a calcium-specific chelator) results from a facilitation of certain adaptive changes of calcium ion disposition that are related to the neurochemical mechanisms of narcotic tolerance and dependence development.
Explore the source record for details and available documents.
In an attempt to explain a loss of cross-tolerance between morphine and methadone and an increased tolerance to methadone lethality in morphine-dependent mice administered methadone orally for six days, the possibility that methadone was stimulating its own metabolism was investigated. It was found that methadone did enhance its own metabolism two-fold. This increase in activity correlated with the development of tolerance to the lethal effects of methadone as measured by an elevation of the oral methadone LD50. Furthermore, SKF-525A, a potent microsomal inhibitor, abolished this tolerance. The intracerbroventricular methadone LD50 was not altered by six days administration of oral methadone, suggesting that the tolerance observed was dispositional in nature.
Explore the source record for details and available documents.
Using a modified tail-flick procedure we have found a highly significant hyperalgesic response in narcotic dependent mice peaking 12 hr following the removal of chronically implanted morphine pellets. Withdrawal-induced hyperalgesia correlated well with other signs of opiate withdrawal behavior. Intracerebroventricular injections of CaCl2, MnCl2 further enhanced the hyperalgesic response in morphine-dependent mice; morphine-dependent mice were more than twice as sensitive to calcium-induced hyperalgesia as placebo-treated controls. On the other hand, i.c.v. injections of the calcium-specific chelator EGTA produced highly significant, dose-dependent antinociceptive responses in both morphine-dependent and control mice, but morphine dependent mice were only half as sensitive to EGTA-induced analgesia as controls. Withdrawal hyperalgesia and EGTA analgesia may be directly related to changes in brain localization of calcium that have been reported previously; it is concluded that morphine and EGTA-induced analgesia may be associated with a calcium depleted state within a relatively small calcium pool of the nerve cell and that opiate withdrawal hyperalgesia is a sensitive measure of narcotic dependency that is likely associated with an increased Ca++ content in the same region.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The uptake of 45Ca2+ by nerve-ending fractions from brains of mice was inhibited in vitro by 10(-9)M concentrations of beta-endorphin and in mice injected intraventricularly with 7 picomoles of beta-endorphin. That the effect was a specific opiate agonist response of beta-endorphin was demonstrated by use of the opiate antagonist, naloxone, which reversed the action. A role for beta-endorphin in the regulation of calcium flux and neurotransmitter release should be considered.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.